Dr. Elena Garralda, MD
Claim this profileHospital Vall d'Hebron
Expert in Solid Tumors
Expert in Cancer
25 reported clinical trials
35 drugs studied
Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
2Cancer
Global LeaderStage IV
MDM2 positive
TP53 negative
Clinical Trials Elena Garralda, MD is currently running
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies (NSCLC)
Recruiting1 award Phase 1 & 2
PC14586
for Solid Tumors
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Recruiting1 award Phase 1 & 25 criteria
More about Elena Garralda, MD
Clinical Trial Related3 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments Elena Garralda, MD has experience with
- Nivolumab
- BI 754091
- BI 1387446
- BI 765179
- Ezabenlimab
- BI 907828
Breakdown of trials Elena Garralda, MD has run
Solid Tumors
Cancer
Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elena Garralda, MD specialize in?
Elena Garralda, MD focuses on Solid Tumors and Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Elena Garralda, MD currently recruiting for clinical trials?
Yes, Elena Garralda, MD is currently recruiting for 8 clinical trials in Barcelona Cataluna. If you're interested in participating, you should apply.
Are there any treatments that Elena Garralda, MD has studied deeply?
Yes, Elena Garralda, MD has studied treatments such as Nivolumab, BI 754091, BI 1387446.
What is the best way to schedule an appointment with Elena Garralda, MD?
Apply for one of the trials that Elena Garralda, MD is conducting.
What is the office address of Elena Garralda, MD?
The office of Elena Garralda, MD is located at: Vall d'Hebron Institute of Oncology, Barcelona, Cataluna 08035 Spain. This is the address for their practice at the Vall d'Hebron Institute of Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.